In reply - 20/08/11
Doi : 10.1016/j.annemergmed.2009.12.016
Leppikangas Heli, MD a, Ruokonen Esko, MD, PhD b, Rutanen Juha, MD, PhD b, Kiviniemi Vesa, PhLic c, Lindgren Leena, MD, PhD d, Kurola Jouni, MD, PhD e
a Department of Anaesthesia, Tampere University Hospital, Tampere, Finland
b Department of Intensive Care, Kuopio University Hospital, Kuopio, Finland
c IT Centre, University of Kuopio, Kuopio, Finland
d Department of Anaesthesia, Tampere University Hospital, Tampere, Finland
e Department of Intensive Care, Kuopio University Hospital, Kuopio, Finland
Le texte complet de cet article est disponible en PDF.
| Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article that might create any potential conflict of interest. See the Manuscript Submission Agreement in this issue for examples of specific conflicts covered by this statement. Financial support provided by Orion Pharma Inc. |
© 2010
American College of Emergency Physicians. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 55 - N° 5
P. 486-487 - mai 2010 Retour au numéro
Article précédent
- In Response to Leppikangas H, et al, Levosimendan as a Rescue Drug in Experimental Propranolol-Induced Myocardial Depression: A Randomized Study
- Daniel M. Lugassy, Alexandra Stefan, Daniel Dexeus, Robert S. Hoffman, Lewis S. Nelson
- Decision Rule for Imaging Utilization in Blunt Abdominal Trauma - Where is Ultrasound?
- Vicki E. Noble, Michael Blaivas, Robert Blankenship, Gerardo Chiricolo, Anthony Dean, J. Christian Fox, Romolo Gaspari, Beatrice Hoffman, Robert Jones, Christopher Moore, Paul Sierzenski, Vivek Tayal, Robert Tillotson
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?